(Q35035116)

English

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Fernando Cabanillas

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

6

object named as

Luis Fayad

0 references

author name string

Gregory M Chronowski

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Richard B Wilder

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Susan L Tucker

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Chul S Ha

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Anas Younes

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Maria A Rodriguez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Fredrick B Hagemeister

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Ibrahim Barista

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

James D Cox

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

55

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

36-43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

EBVD combination chemotherapy plus low dose involved field radiation is a highly effective treatment modality for early stage Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation following chemotherapy for mediastinal Hodgkin's disease: the outcome of various doses for bulky tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of mediastinal involvement in early stage Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignancies after Hodgkin's disease: the Munich experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence Universit

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease: study of treatment intensities and incidences of second malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

LENT SOMA scales for all anatomic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A re-analysis of available dose-response and time-dose data in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An updated dose-response analysis in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease: complications of therapy and excess mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Solid cancer risk after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease - new treatment strategies toward the cure of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903915-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(02)03915-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12504034%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35035116&oldid=1984498077"